-
1
-
-
77951215549
-
Celastrol a triterpene, enhances trail-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors
-
Sung, B.; Park, B.; Yadav, V.R.; Aggarwal, B.B. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J. Biol. Chem. 2010, 285, 11498-11507.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 11498-11507
-
-
Sung, B.1
Park, B.2
Yadav, V.R.3
Aggarwal, B.B.4
-
2
-
-
0034785173
-
A phase i study of ethyl acetate extract of the chinese antirheumatic herb tripterygium wilfordii hook f in rheumatoid arthritis
-
Tao, X.; Cush, J.J.; Garret, M.; Lipsky, P.E. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J. Rheumatol. 2001, 28, 2160-2167.
-
(2001)
J. Rheumatol.
, vol.28
, pp. 2160-2167
-
-
Tao, X.1
Cush, J.J.2
Garret, M.3
Lipsky, P.E.4
-
3
-
-
17444428634
-
Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in balb/c mice
-
Li, H.; Zhang, Y.Y.; Huang, X.Y.; Sun, Y.N.; Jia, Y.F.; Li, D. Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice. Eur. J. Pharmacol. 2005, 512, 231-237.
-
(2005)
Eur. J. Pharmacol.
, vol.512
, pp. 231-237
-
-
Li, H.1
Zhang, Y.Y.2
Huang, X.Y.3
Sun, Y.N.4
Jia, Y.F.5
Li, D.6
-
4
-
-
33744486642
-
Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis
-
Kiaei, M.; Kipiani, K.; Petri, S.; Chen, J.; Calingasan, N.Y.; Beal, M.F. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis. 2005, 2, 246-254.
-
(2005)
Neurodegener Dis.
, vol.2
, pp. 246-254
-
-
Kiaei, M.1
Kipiani, K.2
Petri, S.3
Chen, J.4
Calingasan, N.Y.5
Beal, M.F.6
-
5
-
-
0034752311
-
Celastrol a potent antioxidant and anti-inflammatory drug, as a possible treatment for alzheimer's disease
-
Allison, A.C.; Cacabelos, R.; Lombardi, V.R.; Alvarez, X.A.; Vigo, C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2001, 25, 1341-1357.
-
(2001)
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
, vol.25
, pp. 1341-1357
-
-
Allison, A.C.1
Cacabelos, R.2
Lombardi, V.R.3
Alvarez, X.A.4
Vigo, C.5
-
6
-
-
65549142792
-
Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model
-
Kim, D.Y.; Park, J.W.; Jeoung, D.; Ro, J.Y. Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. Eur. J. Pharmacol. 2009, 612, 98-105.
-
(2009)
Eur. J. Pharmacol.
, vol.612
, pp. 98-105
-
-
Kim, D.Y.1
Park, J.W.2
Jeoung, D.3
Ro, J.Y.4
-
7
-
-
77950234271
-
Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of akt/mammalian target of rapamycin pathway
-
Pang, X.; Yi, Z.; Zhang, J.; Lu, B.; Sung, B.; Qu, W.; Aggarwal, B.B.; Liu, M. Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway. Cancer Res. 2010, 70, 1951-1959.
-
(2010)
Cancer Res.
, vol.70
, pp. 1951-1959
-
-
Pang, X.1
Yi, Z.2
Zhang, J.3
Lu, B.4
Sung, B.5
Qu, W.6
Aggarwal, B.B.7
Liu, M.8
-
8
-
-
33947598693
-
Celastrol a novel triterpene, potentiates tnf-induced apoptosis and suppresses invasion of tumor cells by inhibiting nf-kappab-regulated gene products and tak1-mediated nf-kappab activation
-
Sethi, G.; Ahn, K.S.; Pandey, M.K.; Aggarwal, B.B. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood 2007, 109, 2727-2735.
-
(2007)
Blood
, vol.109
, pp. 2727-2735
-
-
Sethi, G.1
Ahn, K.S.2
Pandey, M.K.3
Aggarwal, B.B.4
-
9
-
-
33646406554
-
Celastrol a triterpene extracted from the chinese "thunder of god vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
-
Yang, H.; Chen, D.; Cui, Q.C.; Yuan, X.; Dou, Q.P. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 2006, 66, 4758-4765.
-
(2006)
Cancer Res.
, vol.66
, pp. 4758-4765
-
-
Yang, H.1
Chen, D.2
Cui, Q.C.3
Yuan, X.4
Dou, Q.P.5
-
10
-
-
42649088411
-
Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing vegfr expression
-
Huang, Y.; Zhou, Y.; Fan, Y.; Zhou, D. Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression. Cancer Lett. 2008, 264, 101-106.
-
(2008)
Cancer Lett.
, vol.264
, pp. 101-106
-
-
Huang, Y.1
Zhou, Y.2
Fan, Y.3
Zhou, D.4
-
11
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA-Cancer J. Clin. 2010, 60, 277-300.
-
(2010)
CA-Cancer J. Clin.
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
12
-
-
78650236850
-
Chemotherapy chemoresistance and the changing treatment landscape for nsclc
-
Chang, A. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 2011, 71, 3-10.
-
(2011)
Lung Cancer
, vol.71
, pp. 3-10
-
-
Chang, A.1
-
13
-
-
68849105058
-
Double egfr mutants containing rare egfr mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations
-
Tam, I.Y.; Leung, E.L.; Tin, V.P.; Chua, D.T.; Sihoe, A.D.; Cheng, L.C.; Chung, L.P.; Wong, M.P. Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations. Mol. Cancer Ther. 2009, 8, 2142-2151.
-
(2009)
Mol. Cancer Ther.
, vol.8
, pp. 2142-2151
-
-
Tam, I.Y.1
Leung, E.L.2
Tin, V.P.3
Chua, D.T.4
Sihoe, A.D.5
Cheng, L.C.6
Chung, L.P.7
Wong, M.P.8
-
14
-
-
67649600824
-
Src promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy
-
Leung, E.L.; Tam, I.Y.; Tin, V.P.; Chua, D.T.; Sihoe, A.D.; Cheng, L.C.; Ho, J.C.; Chung, L.P.; Wong, M.P. SRC promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy. Mol. Cancer Res. 2009, 7, 923-932.
-
(2009)
Mol. Cancer Res.
, vol.7
, pp. 923-932
-
-
Leung, E.L.1
Tam, I.Y.2
Tin, V.P.3
Chua, D.T.4
Sihoe, A.D.5
Cheng, L.C.6
Ho, J.C.7
Chung, L.P.8
Wong, M.P.9
-
15
-
-
65249095599
-
The eml4-Alk fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type egfr and kras
-
Wong, D.W.; Leung, E.L.; So, K.K.; Tam, I.Y.; Sihoe, A.D.; Cheng, L.C.; Ho, K.K.; Au, J.S.; Chung, L.P.; Pik Wong, M. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 2009, 115, 1723-1733.
-
(2009)
Cancer
, vol.115
, pp. 1723-1733
-
-
Wong, D.W.1
Leung, E.L.2
So, K.K.3
Tam, I.Y.4
Sihoe, A.D.5
Cheng, L.C.6
Ho, K.K.7
Au, J.S.8
Chung, L.P.9
Pik Wong, M.10
-
16
-
-
84864835466
-
The oncogenic lung cancer fusion kinase cd74-ros activates a novel invasiveness pathway through e-syt1 phosphorylation
-
Jun, H.J.; Johnson, H.; Bronson, R.T.; de Feraudy, S.; White, F.; Charest, A. The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation. Cancer Res. 2012, 72, 3764-3774.
-
(2012)
Cancer Res.
, vol.72
, pp. 3764-3774
-
-
Jun, H.J.1
Johnson, H.2
Bronson, R.T.3
De Feraudy, S.4
White, F.5
Charest, A.6
-
17
-
-
0142119289
-
Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis
-
Hirsch, F.R.; Varella-Garcia, M.; Bunn, P.A., Jr.; di Maria, M.V.; Veve, R.; Bremmes, R.M.; Baron, A.E.; Zeng, C.; Franklin, W.A. Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis. J. Clin. Oncol. 2003, 21, 3798-3807.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 3798-3807
-
-
Hirsch, F.R.1
Varella-Garcia, M.2
Bunn Jr., P.A.3
Di Maria, M.V.4
Veve, R.5
Bremmes, R.M.6
Baron, A.E.7
Zeng, C.8
Franklin, W.A.9
-
18
-
-
9144256014
-
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
-
Selvaggi, G.; Novello, S.; Torri, V.; Leonardo, E.; de Giuli, P.; Borasio, P.; Mossetti, C.; Ardissone, F.; Lausi, P.; Scagliotti, G.V. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann. Oncol. 2004, 15, 28-32.
-
(2004)
Ann. Oncol.
, vol.15
, pp. 28-32
-
-
Selvaggi, G.1
Novello, S.2
Torri, V.3
Leonardo, E.4
De Giuli, P.5
Borasio, P.6
Mossetti, C.7
Ardissone, F.8
Lausi, P.9
Scagliotti, G.V.10
-
19
-
-
33846202907
-
Molecular mechanisms of epidermal growth factor receptor (egfr) activation and response to gefitinib and other egfr-targeting drugs
-
Ono, M.; Kuwano, M. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin. Cancer Res. 2006, 12, 7242-7251.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 7242-7251
-
-
Ono, M.1
Kuwano, M.2
-
20
-
-
80051746642
-
Curcumin induces egfr degradation in lung adenocarcinoma and modulates p38 activation in intestine: The versatile adjuvant for gefitinib therapy
-
Lee, J.Y.; Lee, Y.M.; Chang, G.C.; Yu, S.L.; Hsieh, W.Y.; Chen, J.J.; Chen, H.W.; Yang, P.C. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: The versatile adjuvant for gefitinib therapy. PLoS One 2011, 6, e23756.
-
(2011)
PLoS One
, vol.6
-
-
Lee, J.Y.1
Lee, Y.M.2
Chang, G.C.3
Yu, S.L.4
Hsieh, W.Y.5
Chen, J.J.6
Chen, H.W.7
Yang, P.C.8
-
21
-
-
79953118839
-
Genotypic and histological evolution of lung cancers acquiring resistance to egfr inhibitors
-
doi:10.1126/scitranslmed.3002003
-
Sequist, L.V.; Waltman, B.A.; Dias-Santagata, D.; Digumarthy, S.; Turke, A.B.; Fidias, P.; Bergethon, K.; Shaw, A.T.; Gettinger, S.; Cosper, A.K.; et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci. Transl. Med. 2011, 3, doi:10.1126/scitranslmed.3002003.
-
Sci. Transl. Med
, vol.2011
, pp. 3
-
-
Sequist, L.V.1
Waltman, B.A.2
Dias-Santagata, D.3
Digumarthy, S.4
Turke, A.B.5
Fidias, P.6
Bergethon, K.7
Shaw, A.T.8
Gettinger, S.9
Cosper, A.K.10
-
22
-
-
84877926897
-
Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
-
Sudo, M.; Chin, T.M.; Mori, S.; Doan, N.B.; Said, J.W.; Akashi, M.; Koeffler, H.P. Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer. Cancer Chemother. Pharmacol. 2013, 71, 1325-1334.
-
(2013)
Cancer Chemother. Pharmacol.
, vol.71
, pp. 1325-1334
-
-
Sudo, M.1
Chin, T.M.2
Mori, S.3
Doan, N.B.4
Said, J.W.5
Akashi, M.6
Koeffler, H.P.7
-
23
-
-
77953078857
-
Combined inhibition of igfr enhances the effects of gefitinib in h1650: A lung cancer cell line with egfr mutation and primary resistance to egfr-tk inhibitors
-
Choi, Y.J.; Rho, J.K.; Jeon, B.S.; Choi, S.J.; Park, S.C.; Lee, S.S.; Kim, H.R.; Kim, C.H.; Lee, J.C. Combined inhibition of IGFR enhances the effects of gefitinib in H1650: A lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors. Cancer Chemother. Pharmacol. 2010, 66, 381-388.
-
(2010)
Cancer Chemother. Pharmacol.
, vol.66
, pp. 381-388
-
-
Choi, Y.J.1
Rho, J.K.2
Jeon, B.S.3
Choi, S.J.4
Park, S.C.5
Lee, S.S.6
Kim, H.R.7
Kim, C.H.8
Lee, J.C.9
-
24
-
-
79953046542
-
Fas and nf-kappab signalling modulate dependence of lung cancers on mutant egfr
-
Bivona, T.G.; Hieronymus, H.; Parker, J.; Chang, K.; Taron, M.; Rosell, R.; Moonsamy, P.; Dahlman, K.; Miller, V.A.; Costa, C.; et al. FAS and NF-kappaB signalling modulate dependence of lung cancers on mutant EGFR. Nature 2011, 471, 523-526.
-
(2011)
Nature
, vol.471
, pp. 523-526
-
-
Bivona, T.G.1
Hieronymus, H.2
Parker, J.3
Chang, K.4
Taron, M.5
Rosell, R.6
Moonsamy, P.7
Dahlman, K.8
Miller, V.A.9
Costa, C.10
-
25
-
-
41649111490
-
Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells
-
Kim, H.P.; Han, S.W.; Kim, S.H.; Im, S.A.; Oh, D.Y.; Bang, Y.J.; Kim, T.Y. Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells. Mol. Cancer Ther. 2008, 7, 607-615.
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 607-615
-
-
Kim, H.P.1
Han, S.W.2
Kim, S.H.3
Im, S.A.4
Oh, D.Y.5
Bang, Y.J.6
Kim, T.Y.7
-
26
-
-
48249114422
-
Eml4-Alk fusion gene and efficacy of an alk kinase inhibitor in lung cancer
-
Koivunen, J.P.; Mermel, C.; Zejnullahu, K.; Murphy, C.; Lifshits, E.; Holmes, A.J.; Choi, H.G.; Kim, J.; Chiang, D.; Thomas, R.; et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin. Cancer Res. 2008, 14, 4275-4283.
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 4275-4283
-
-
Koivunen, J.P.1
Mermel, C.2
Zejnullahu, K.3
Murphy, C.4
Lifshits, E.5
Holmes, A.J.6
Choi, H.G.7
Kim, J.8
Chiang, D.9
Thomas, R.10
-
27
-
-
79957808725
-
Olaquindox induces apoptosis through the mitochondrial pathway in hepg2 cells
-
Zou, J.; Chen, Q.; Jin, X.; Tang, S.; Chen, K.; Zhang, T.; Xiao, X. Olaquindox induces apoptosis through the mitochondrial pathway in HepG2 cells. Toxicology 2011, 285, 104-113.
-
(2011)
Toxicology
, vol.285
, pp. 104-113
-
-
Zou, J.1
Chen, Q.2
Jin, X.3
Tang, S.4
Chen, K.5
Zhang, T.6
Xiao, X.7
-
28
-
-
34250760931
-
Flex-hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria
-
Liu, T.; Hannafon, B.; Gill, L.; Kelly, W.; Benbrook, D. Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria. Mol. Cancer Ther. 2007, 6, 1814-1822.
-
(2007)
Mol. Cancer Ther.
, vol.6
, pp. 1814-1822
-
-
Liu, T.1
Hannafon, B.2
Gill, L.3
Kelly, W.4
Benbrook, D.5
-
29
-
-
81855218666
-
Shikonin a chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma
-
Gong, K.; Li, W. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma. Free Radic. Biol. Med. 2011, 51, 2259-2271.
-
(2011)
Free Radic. Biol. Med.
, vol.51
, pp. 2259-2271
-
-
Gong, K.1
Li, W.2
-
30
-
-
32444434664
-
Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis
-
Lakhani, S.A.; Masud, A.; Kuida, K.; Porter, G.A., Jr.; Booth, C.J.; Mehal, W.Z.; Inayat, I.; Flavell, R.A. Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis. Science 2006, 311, 847-851.
-
(2006)
Science
, vol.311
, pp. 847-851
-
-
Lakhani, S.A.1
Masud, A.2
Kuida, K.3
Porter Jr., G.A.4
Booth, C.J.5
Mehal, W.Z.6
Inayat, I.7
Flavell, R.A.8
-
32
-
-
27644584179
-
Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a nur77-dependent pathway
-
Maddika, S.; Booy, E.P.; Johar, D.; Gibson, S.B.; Ghavami, S.; Los, M. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J. Cell Sci. 2005, 118, 4485-4493.
-
(2005)
J. Cell Sci.
, vol.118
, pp. 4485-4493
-
-
Maddika, S.1
Booy, E.P.2
Johar, D.3
Gibson, S.B.4
Ghavami, S.5
Los, M.6
-
33
-
-
67349200795
-
The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in fl cells
-
Eeva, J.; Nuutinen, U.; Ropponen, A.; Matto, M.; Eray, M.; Pellinen, R.; Wahlfors, J.; Pelkonen, J. The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells. Apoptosis 2009, 14, 687-698.
-
(2009)
Apoptosis
, vol.14
, pp. 687-698
-
-
Eeva, J.1
Nuutinen, U.2
Ropponen, A.3
Matto, M.4
Eray, M.5
Pellinen, R.6
Wahlfors, J.7
Pelkonen, J.8
-
34
-
-
79955855304
-
Celastrol targets mitochondrial respiratory chain complex i to induce reactive oxygen species-dependent cytotoxicity in tumor cells
-
Chen, G.; Zhang, X.; Zhao, M.; Wang, Y.; Cheng, X.; Wang, D.; Xu, Y.; Du, Z.; Yu, X. Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells. BMC Cancer 2011, 11, 170.
-
(2011)
BMC Cancer
, vol.11
, pp. 170
-
-
Chen, G.1
Zhang, X.2
Zhao, M.3
Wang, Y.4
Cheng, X.5
Wang, D.6
Xu, Y.7
Du, Z.8
Yu, X.9
-
35
-
-
62949238913
-
New developments in hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
-
Li, Y.; Zhang, T.; Schwartz, S.J.; Sun, D. New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential. Drug Resist. Updat. 2009, 12, 17-27.
-
(2009)
Drug Resist. Updat.
, vol.12
, pp. 17-27
-
-
Li, Y.1
Zhang, T.2
Schwartz, S.J.3
Sun, D.4
-
36
-
-
33749340253
-
Detection of egfr mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis
-
Nomoto, K.; Tsuta, K.; Takano, T.; Fukui, T.; Yokozawa, K.; Sakamoto, H.; Yoshida, T.; Maeshima, A.M.; Shibata, T.; Furuta, K.; et al. Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis. Am. J. Clin. Pathol. 2006, 126, 608-615.
-
(2006)
Am. J. Clin. Pathol.
, vol.126
, pp. 608-615
-
-
Nomoto, K.1
Tsuta, K.2
Takano, T.3
Fukui, T.4
Yokozawa, K.5
Sakamoto, H.6
Yoshida, T.7
Maeshima, A.M.8
Shibata, T.9
Furuta, K.10
-
37
-
-
70449412700
-
The nf-kappa b inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
-
He, D.; Xu, Q.; Yan, M.; Zhang, P.; Zhou, X.; Zhang, Z.; Duan, W.; Zhong, L.; Ye, D.; Chen, W. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer 2009, 9, 343.
-
(2009)
BMC Cancer
, vol.9
, pp. 343
-
-
He, D.1
Xu, Q.2
Yan, M.3
Zhang, P.4
Zhou, X.5
Zhang, Z.6
Duan, W.7
Zhong, L.8
Ye, D.9
Chen, W.10
-
38
-
-
84872841568
-
Schizandrin protects primary rat cortical cell cultures from glutamate-induced apoptosis by inhibiting activation of the mapk family and the mitochondria dependent pathway
-
Lee, M.S.; Chao, J.; Yen, J.C.; Lin, L.W.; Tsai, F.S.; Hsieh, M.T.; Peng, W.H.; Cheng, H.Y. Schizandrin protects primary rat cortical cell cultures from glutamate-induced apoptosis by inhibiting activation of the MAPK family and the mitochondria dependent pathway. Molecules 2012, 18, 354-72.
-
(2012)
Molecules
, vol.18
, pp. 354-372
-
-
Lee, M.S.1
Chao, J.2
Yen, J.C.3
Lin, L.W.4
Tsai, F.S.5
Hsieh, M.T.6
Peng, W.H.7
Cheng, H.Y.8
-
39
-
-
49149088537
-
Induction of apoptosis by shikonin through a ros/jnkmediated process in bcr/abl-positive chronic myelogenous leukemia (cml) cells
-
Mao, X.; Yu, C.R.; Li, W.H.; Li, W.X. Induction of apoptosis by shikonin through a ROS/JNKmediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res. 2008, 18, 879-888.
-
(2008)
Cell Res.
, vol.18
, pp. 879-888
-
-
Mao, X.1
Yu, C.R.2
Li, W.H.3
Li, W.X.4
-
40
-
-
67650930911
-
Heat-shock protein 90 (hsp90) as a molecular target for therapy of gastrointestinal cancer
-
Moser, C.; Lang, S.A.; Stoeltzing, O. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer. Anticancer Res. 2009, 29, 2031-2042.
-
(2009)
Anticancer Res.
, vol.29
, pp. 2031-2042
-
-
Moser, C.1
Lang, S.A.2
Stoeltzing, O.3
-
41
-
-
0037131187
-
Akt forms an intracellular complex with heat shock protein 90 (hsp90) and cdc37 and is destabilized by inhibitors of hsp90 function
-
Basso, A.D.; Solit, D.B.; Chiosis, G.; Giri, B.; Tsichlis, P.; Rosen, N. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 2002, 277, 39858-39866.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 39858-39866
-
-
Basso, A.D.1
Solit, D.B.2
Chiosis, G.3
Giri, B.4
Tsichlis, P.5
Rosen, N.6
-
42
-
-
0028786332
-
Disruption of the raf-1-hsp90 molecular complex results in destabilization of raf-1 and loss of raf-1-ras association
-
Schulte, T.W.; Blagosklonny, M.V.; Ingui, C.; Neckers, L. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J. Biol. Chem. 1995, 270, 24585-24588.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 24585-24588
-
-
Schulte, T.W.1
Blagosklonny, M.V.2
Ingui, C.3
Neckers, L.4
-
43
-
-
39049150922
-
Inhibition of hsp90 down-regulates mutant epidermal growth factor receptor (egfr) expression and sensitizes egfr mutant tumors to paclitaxel
-
Sawai, A.; Chandarlapaty, S.; Greulich, H.; Gonen, M.; Ye, Q.; Arteaga, C.L.; Sellers, W.; Rosen, N.; Solit, D.B. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Cancer Res. 2008, 68, 589-596.
-
(2008)
Cancer Res.
, vol.68
, pp. 589-596
-
-
Sawai, A.1
Chandarlapaty, S.2
Greulich, H.3
Gonen, M.4
Ye, Q.5
Arteaga, C.L.6
Sellers, W.7
Rosen, N.8
Solit, D.B.9
-
44
-
-
38649119730
-
Signaling networks assembled by oncogenic egfr and c-met
-
Guo, A.; Villen, J.; Kornhauser, J.; Lee, K.A.; Stokes, M.P.; Rikova, K.; Possemato, A.; Nardone, J.; Innocenti, G.; Wetzel, R.; et al. Signaling networks assembled by oncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. USA 2008, 105, 692-697.
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 692-697
-
-
Guo, A.1
Villen, J.2
Kornhauser, J.3
Lee, K.A.4
Stokes, M.P.5
Rikova, K.6
Possemato, A.7
Nardone, J.8
Innocenti, G.9
Wetzel, R.10
-
45
-
-
84894042781
-
Cancerous inhibitor of pp2a is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
-
doi:10.1093/carcin/bgt395
-
Liu, Z.; Ma, L.; Wen, Z.S.; Hu, Z.; Wu, F.Q.; Li, W.; Liu, J.; Zhou, G.B. Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer. Carcinogenesis 2013, doi:10.1093/carcin/bgt395.
-
Carcinogenesis
, vol.2013
-
-
Liu, Z.1
Ma, L.2
Wen, Z.S.3
Hu, Z.4
Wu, F.Q.5
Li, W.6
Liu, J.7
Zhou, G.B.8
-
46
-
-
79957961355
-
Celastrol induces apoptosis in non-small-cell lung cancer a549 cells through activation of mitochondria- and fas/fasl-mediated pathways
-
Mou, H.; Zheng, Y.; Zhao, P.; Bao, H.; Fang, W.; Xu, N. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. Toxicol. In Vitro 2011, 25, 1027-1032.
-
(2011)
Toxicol. In Vitro
, vol.25
, pp. 1027-1032
-
-
Mou, H.1
Zheng, Y.2
Zhao, P.3
Bao, H.4
Fang, W.5
Xu, N.6
|